Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionBbr Partners, Llc
Latest Disclosed Ownership5,580 shares
Latest Disclosed Value $ 1,963,323
Bbr Partners, Llc reports 21.24% decrease in ownership of AMGN / Amgen Inc.

On May 12, 2026 - Bbr Partners, Llc filed a 13F-HR form disclosing ownership of 5,580 shares of Amgen Inc. (MX:AMGN) valued at $1,963,323 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 7,085 shares of Amgen Inc.. This represents a change in shares of -21.24% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AMGEN COM 031162100 5,580 -1,505 -21.24 1,963 -15.31 0.1096
2026-02-10 2025-12-31 13F AMGEN COM 031162100 7,085 -32 -0.45 2,319 15.44 0.1244
2025-11-07 2025-09-30 13F AMGEN COM 031162100 7,117 32 0.45 2,008 1.52 0.1158
2025-08-14 2025-06-30 13F AMGEN COM 031162100 7,085 846 13.56 1,978 1.80 0.1231
2025-05-14 2025-03-31 13F AMGEN COM 031162100 6,239 0 0.00 1,944 19.50 0.1373
2025-02-07 2024-12-31 13F AMGEN COM 031162100 6,239 -53 -0.84 1,626 -19.78 0.1135
2024-11-13 2024-09-30 13F AMGEN COM 031162100 6,292 -56 -0.88 2,027 2.22 0.1545
2024-08-05 2024-06-30 13F Amgen COM 031162100 6,348 -723 -10.22 1,983 -1.34 0.1625
2024-05-14 2024-03-31 13F AMGEN COM 031162100 7,071 825 13.21 2,010 11.79 0.1610
2024-02-13 2023-12-31 13F AMGEN COM 031162100 6,246 -588 -8.60 1,799 -2.07 0.1839
2023-11-14 2023-09-30 13F AMGEN COM 031162100 6,834 6,834 1,837 0.2066
2022-11-10 2022-09-30 13F AMGEN COM 031162100 0 -2,235 -100.00 0 -100.00
2022-08-12 2022-06-30 13F AMGEN COM 031162100 2,235 0 0.00 544 0.74 0.0636
2022-05-16 2022-03-31 13F AMGEN COM 031162100 2,235 95 4.44 540 12.27 0.0509
2022-02-08 2021-12-31 13F AMGEN COM 031162100 2,140 405 23.34 481 30.35 0.0565
2021-11-12 2021-09-30 13F AMGEN COM 031162100 1,735 -53 -2.96 369 -15.37 0.0305
2021-08-13 2021-06-30 13F AMGEN COM 031162100 1,788 18 1.02 436 -0.91 0.0345
2021-05-17 2021-03-31 13F AMGEN COM 031162100 1,770 3 0.17 440 8.37 0.0361
2021-02-16 2020-12-31 13F AMGEN COM 031162100 1,767 32 1.84 406 -7.94 0.0336
2020-11-12 2020-09-30 13F AMGEN COM 031162100 1,735 1,735 441 0.0378
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.